After subcutaneous single dose administrations, C max and AUC of liraglutide increased proportionally over the therapeutic dose range of 0.6 mg to 1.8 mg.
Evidence role
Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model
human
Condition
Route: subcutaneous · Liraglutide · 5a9ef4ea-c76a-4d34-a604-27c5b505f5a4 · 12.3 Pharmacokinetics · cmax auc dose proportionality text · After subcutaneous single dose administrations, C max and AUC of...
